Your browser (Internet Explorer 7 or lower) is out of date. It has known security flaws and may not display all features of this and other websites. Learn how to update your browser.

X

Navigate / search

Building on High Impact Basic Neurobiology Through Assay Development: Advancing Tools for Therapeutic Discovery (R01)

Key Dates: 
  • Posted Date: December 10, 2014
  • Open Date (Earliest Submission Date): January 23, 2015
  • Letter of Intent Due Date(s): Not Applicable
  • Application Due Date(s): February 23, 2015 and Standard dates thereafter apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • AIDS Application Due Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Scientific Merit Review: Standard dates apply
  • Advisory Council Review: Standard dates apply
  • Earliest Start Date: Standard dates apply
Purpose: 

This funding opportunity announcement (FOA) encourages research grant applications from institutions/organizations to develop novel, robust assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function with the intent to probe mechanisms or perturbations in an unbiased and efficient manner. These novel assays would provide opportunities to measure neurobiological endpoints and build a pipeline to be used in the context of target identification and drug discovery.

Expiration Date: 
Monday, January 8, 2018
Announcement Number: 
PAR-15-066